Medtech startup Berlin Heals aims to advance heart failure therapy with its implantable C-MIC (Cardiac Microcurrent) device. Following positive pilot tests in patients, the startup seeks to obtain a CE certification and FDA approval. The invested CHF 6 million from Swiss company Fumedica and further investors will facilitate the process.
